The B7–CD28 superfamily

[1]  P. Linsley,et al.  Comparative Analysis of B 7-1 and B 7-2 Costimulatory Ligands : Expression and Function , 2003 .

[2]  G. Freeman,et al.  PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2 , 2002, European journal of immunology.

[3]  E. Clark,et al.  Tumor Necrosis Factor-α Regulates the Expression of Inducible Costimulator Receptor Ligand on CD34+ Progenitor Cells during Differentiation into Antigen Presenting Cells* , 2001, The Journal of Biological Chemistry.

[4]  T. Okazaki,et al.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Sperling.  ICOS costimulation: is it the key to selective immunotherapy? , 2001, Clinical Immunology.

[6]  J. Ledbetter,et al.  ICOS ligand costimulation is required for T-cell encephalitogenicity. , 2001, Clinical immunology.

[7]  P. Perrin,et al.  Costimulation of memory T-cells by ICOS: a potential therapeutic target for autoimmunity? , 2001, Clinical immunology.

[8]  J. Bluestone,et al.  Inducible Costimulator Regulates Th2-Mediated Inflammation, but Not Th2 Differentiation, in a Model of Allergic Airway Disease1 , 2001, The Journal of Immunology.

[9]  T. Boehm,et al.  Laser capture microdissection‐based expression profiling identifies PD1‐ligand as a target of the nude locus gene product , 2001, European journal of immunology.

[10]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[11]  J. Gutiérrez-Ramos,et al.  The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE , 2001, Nature Immunology.

[12]  J. Gutiérrez-Ramos,et al.  Importance of ICOS–B7RP-1 costimulation in acute and chronic allograft rejection , 2001, Nature Immunology.

[13]  R. Kroczek,et al.  ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses , 2001, Nature Immunology.

[14]  W. Sha,et al.  Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation1 , 2001, The Journal of Immunology.

[15]  K. Nichols,et al.  CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1 , 2001, The Journal of Immunology.

[16]  P. Blair,et al.  ICOS Costimulation Requires IL-2 and Can Be Prevented by CTLA-4 Engagement1 , 2001, The Journal of Immunology.

[17]  D. Pardoll,et al.  B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells , 2001, The Journal of experimental medicine.

[18]  J. Egen,et al.  CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. , 2001, Annual review of immunology.

[19]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[20]  Yan Zhang,et al.  Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses , 2001, Nature.

[21]  R. Flavell,et al.  Cutting Edge: Critical Role of Inducible Costimulator in Germinal Center Reactions1 , 2001, The Journal of Immunology.

[22]  G. Zhu,et al.  B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. , 2001, Blood.

[23]  R. Peach,et al.  CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. , 2001, The American journal of pathology.

[24]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[25]  G. Zhu,et al.  B7-H3: A costimulatory molecule for T cell activation and IFN-γ production , 2001, Nature Immunology.

[26]  Christopher C. Goodnow,et al.  A genomic view of immunology , 2001, Nature.

[27]  S. Beck,et al.  The cluster of BTN genes in the extended major histocompatibility complex. , 2001, Genomics.

[28]  A. Sharpe,et al.  CTLA-4 regulates induction of anergy in vivo. , 2001, Immunity.

[29]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[30]  T. Pawson,et al.  ICOS is essential for effective T-helper-cell responses , 2001, Nature.

[31]  G. Freeman,et al.  ICOS is critical for CD40-mediated antibody class switching , 2001, Nature.

[32]  J. Allison,et al.  ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.

[33]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.

[34]  H. Ochs,et al.  Induction, binding specificity and function of human ICOS , 2000, European journal of immunology.

[35]  U. Dianzani,et al.  The T cell activation molecule H4 and the CD28‐like molecule ICOS are identical , 2000, European journal of immunology.

[36]  G. Freeman,et al.  Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1 , 2000, The Journal of Immunology.

[37]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[38]  D. Sansom,et al.  CD28, CTLA‐4 and their ligands: who does what and to whom? , 2000, Immunology.

[39]  T. Boone,et al.  Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. , 2000, International immunology.

[40]  K. Sakamaki,et al.  Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family. , 2000, Biochemical and biophysical research communications.

[41]  H. Lassmann,et al.  Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis1 , 2000, The Journal of Immunology.

[42]  P. Libby,et al.  Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. , 2000, The American journal of pathology.

[43]  Mats Wahlgren,et al.  The Semiconserved Head Structure of Plasmodium falciparum Erythrocyte Membrane Protein 1 Mediates Binding to Multiple Independent Host Receptors , 2000, The Journal of experimental medicine.

[44]  A. Oxenius,et al.  Inducible Costimulator Protein (Icos) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection , 2000, The Journal of experimental medicine.

[45]  S. Lehar,et al.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. , 2000, Immunity.

[46]  E. Clark,et al.  Characterization of Human Inducible Costimulator Ligand Expression and Function1 , 2000, The Journal of Immunology.

[47]  H. Himmelbauer,et al.  Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand , 2000, European journal of immunology.

[48]  L. Rowen,et al.  BTL-II : a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse , 2000, Immunogenetics.

[49]  S. Davis,et al.  LICOS, a primordial costimulatory ligand? , 2000, Current Biology.

[50]  T. Honjo,et al.  Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice , 2000, The Journal of experimental medicine.

[51]  Paul W. Wu,et al.  Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor , 2000, The Journal of Immunology.

[52]  I H Mather,et al.  A review and proposed nomenclature for major proteins of the milk-fat globule membrane. , 2000, Journal of dairy science.

[53]  D I Stuart,et al.  Structure and dimerization of a soluble form of B7-1. , 2000, Immunity.

[54]  A. Shaw,et al.  CD28 and T cell co-stimulation. , 2000, Reviews in immunogenetics.

[55]  G. Zhu,et al.  Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. , 2000, Blood.

[56]  T. Mak,et al.  T-cell co-stimulation through B7RP-1 and ICOS , 1999, Nature.

[57]  G. Zhu,et al.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion , 1999, Nature Medicine.

[58]  W. Sha,et al.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.

[59]  V. Kuchroo,et al.  Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.

[60]  T. Honjo,et al.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.

[61]  A. Sharpe,et al.  CTLA-4 and T cell activation. , 1999, Current opinion in immunology.

[62]  J. Allison,et al.  CTLA-4-Mediated inhibition of early events of T cell proliferation. , 1999, Journal of immunology.

[63]  M. Whitlow,et al.  Protein fold analysis of the B30.2‐like domain , 1999, Proteins.

[64]  E. Lavi,et al.  Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice. , 1999, Clinical immunology.

[65]  A. Sharpe,et al.  B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) , 1999, The Journal of experimental medicine.

[66]  A. Lanzavecchia,et al.  From TCR Engagement to T Cell Activation A Kinetic View of T Cell Behavior , 1999, Cell.

[67]  P. Bretscher,et al.  A two-step, two-signal model for the primary activation of precursor helper T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[68]  A. Lanzavecchia,et al.  From TCR Engagement to Minireview T Cell Activation: A Kinetic View of T Cell Behavior , 1999 .

[69]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[70]  T. Honjo,et al.  Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. , 1998, International immunology.

[71]  A. Sharpe,et al.  The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells , 1998, Immunological reviews.

[72]  R. Ceriani,et al.  Milk Fat Globule Glycoproteins in Human Milk and in Gastric Aspirates of Mother's Milk-Fed Preterm Infants , 1998, Pediatric Research.

[73]  H. Weiner,et al.  IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.

[74]  J. Bluestone,et al.  Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease , 1998, Journal of Neuroimmunology.

[75]  E. Shevach,et al.  An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease , 1998, The Journal of experimental medicine.

[76]  V. Vakharia,et al.  Butyrophilin Is Expressed in Mammary Epithelial Cells from a Single-sized Messenger RNA as a Type I Membrane Glycoprotein* , 1998, The Journal of Biological Chemistry.

[77]  M. Suyama,et al.  Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. , 1998, DNA research : an international journal for rapid publication of reports on genes and genomes.

[78]  F. Traganos,et al.  Activation-induced expression of human programmed death-1 gene in T-lymphocytes. , 1997, Experimental cell research.

[79]  T. Strom,et al.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.

[80]  E. Simpson,et al.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.

[81]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. , 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

[82]  J. Bluestone,et al.  CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. , 1996, Journal of immunology.

[83]  C. June,et al.  CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. , 1996, Journal of immunology.

[84]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[85]  K. Bennett,et al.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.

[86]  J. Bluestone,et al.  CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301] , 1996, The Journal of experimental medicine.

[87]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[88]  T. Honjo,et al.  Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. , 1996, International immunology.

[89]  T. Honjo,et al.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. , 1996, International immunology.

[90]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[91]  N. Aoki,et al.  Carboxy-terminal cytoplasmic domain of mouse butyrophilin specifically associates with a 150-kDa protein of mammary epithelial cells and milk fat globule membrane. , 1995, Biochimica et biophysica acta.

[92]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[93]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[94]  J. Allison,et al.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.

[95]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[96]  D. Loh,et al.  Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. , 1995, Journal of immunology.

[97]  P. Linsley,et al.  Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.

[98]  P. Linsley,et al.  Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1 , 1994, The Journal of experimental medicine.

[99]  M. Taniwaki,et al.  Structure and chromosomal localization of the human PD-1 gene (PDCD1). , 1994, Genomics.

[100]  P. Linsley,et al.  Extending the B7 (CD80) gene family , 1994, Protein science : a publication of the Protein Society.

[101]  P. Linsley,et al.  CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.

[102]  P. Linsley,et al.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function , 1994, The Journal of experimental medicine.

[103]  J. Gribben,et al.  Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production , 1993, The Journal of experimental medicine.

[104]  J. Gribben,et al.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. , 1993, Science.

[105]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[106]  K P Lee,et al.  Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.

[107]  P. Allen,et al.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.

[108]  P. Linsley,et al.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes , 1992, The Journal of experimental medicine.

[109]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[110]  J. Allison,et al.  Identification and distribution of the costimulatory receptor CD28 in the mouse. , 1992, Journal of immunology.

[111]  P. Linsley,et al.  CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.

[112]  J. Gribben,et al.  Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7 , 1991, The Journal of experimental medicine.

[113]  J. Allison,et al.  The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. , 1990, Journal of immunology.

[114]  C. Thompson,et al.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[115]  B. Seed,et al.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[116]  G. Freeman,et al.  B7, a B-cell-restricted antigen that identifies preactivated B cells. , 1987, Journal of immunology.

[117]  F. Denizot,et al.  A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.

[118]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[119]  T. Yokochi,et al.  B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. , 1982, Journal of immunology.

[120]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.